NasdaqGM - Nasdaq Real Time Price USD
iTeos Therapeutics, Inc. (ITOS)
7.81
-0.16
(-2.01%)
At close: May 16 at 4:00:01 PM EDT
8.12
+0.31
+(3.97%)
After hours: May 16 at 7:41:39 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 4 | 4 |
| Avg. Estimate | -0.78 | -0.66 | -2.93 | -2.64 |
| Low Estimate | -0.83 | -1.02 | -3.84 | -3.69 |
| High Estimate | -0.72 | -0.36 | -2.23 | -1.49 |
| Year Ago EPS | -0.18 | -1.05 | -3.32 | -2.93 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 6 | 6 | 6 | 6 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | 35M | -- | 35M | -- |
| Sales Growth (year/est) | -100.00% | 0.00% | -100.00% | 0.00% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.95 | -1.16 | -1.02 | -0.9 |
| EPS Actual | -0.18 | -1.05 | -1.03 | -0.8 |
| Difference | 0.77 | 0.11 | -0.01 | 0.1 |
| Surprise % | 81.09% | 9.87% | -0.82% | 11.46% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.78 | -0.66 | -2.93 | -2.64 |
| 7 Days Ago | -0.88 | -0.97 | -3.43 | -3.89 |
| 30 Days Ago | -0.94 | -0.94 | -3.77 | -3.98 |
| 60 Days Ago | -0.94 | -0.94 | -3.77 | -3.98 |
| 90 Days Ago | -0.98 | -0.96 | -3.66 | -3.87 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 2 | 1 | 3 | 2 |
| Up Last 30 Days | 2 | 1 | 3 | 2 |
| Down Last 7 Days | 2 | 3 | 1 | 1 |
| Down Last 30 Days | 2 | 3 | 1 | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ITOS | -331.82% | 37.25% | 11.72% | 9.98% |
| S&P 500 | 13.21% | 2.76% | 7.83% | 13.78% |
Upgrades & Downgrades
| Downgrade | HC Wainwright & Co.: Buy to Neutral | 5/14/2025 |
| Maintains | Piper Sandler: Overweight to Overweight | 5/14/2025 |
| Maintains | Wells Fargo: Overweight to Overweight | 5/14/2025 |
| Downgrade | Leerink Partners: Outperform to Market Perform | 5/14/2025 |
| Downgrade | JP Morgan: Overweight to Neutral | 5/13/2025 |
| Maintains | Wells Fargo: Overweight to Overweight | 4/29/2025 |
Related Tickers
ASMB Assembly Biosciences, Inc.
13.42
+7.36%
CYTK Cytokinetics, Incorporated
31.00
+3.89%
KROS Keros Therapeutics, Inc.
14.07
+0.29%
CRGX CARGO Therapeutics, Inc.
4.1200
+3.26%
SEER Seer, Inc.
2.0700
-0.48%
GLPG Galapagos NV
27.75
+3.31%
HLVX HilleVax, Inc.
1.9700
+0.51%
VTYX Ventyx Biosciences, Inc.
1.4000
+15.70%
IPSC Century Therapeutics, Inc.
0.5600
+8.23%
RPTX Repare Therapeutics Inc.
1.3400
+0.75%